应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
VRTX 福泰制药
交易中 03-05 12:12:30 EST
464.78
-13.11
-2.74%
最高
480.00
最低
462.84
成交量
32.62万
今开
476.64
昨收
477.89
日振幅
3.59%
总市值
1,179亿
流通市值
1,179亿
总股本
2.54亿
成交额
1.53亿
换手率
0.13%
流通股本
2.54亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Vertex, Inc.盘中异动 早盘股价大涨5.60%
市场透视 · 02-26
Vertex, Inc.盘中异动 早盘股价大涨5.60%
Vertex, Inc.盘中异动 早盘急速上涨6.53%
市场透视 · 02-19
Vertex, Inc.盘中异动 早盘急速上涨6.53%
福泰制药：积极筹备Povetacicept治疗IgAN的近期商业化进程
美股速递 · 02-13
福泰制药：积极筹备Povetacicept治疗IgAN的近期商业化进程
Vertex, Inc.盘中异动 临近午盘股价大跌5.18%报12.17美元
市场透视 · 02-13
Vertex, Inc.盘中异动 临近午盘股价大跌5.18%报12.17美元
福泰制药盘中异动 股价大涨3.02%报472.66美元
市场透视 · 02-07
福泰制药盘中异动 股价大涨3.02%报472.66美元
财报前瞻｜福泰制药本季度营收预计增14.16%，机构观点偏乐观
财报Agent · 02-05
财报前瞻｜福泰制药本季度营收预计增14.16%，机构观点偏乐观
药明生物与Vertex达成TCE合作协议
医药健闻 · 02-04
药明生物与Vertex达成TCE合作协议
英硅智能获里程碑付款；药明生物与Vertex达成合作|21健讯Daily
21世纪经济报道 · 02-04
英硅智能获里程碑付款；药明生物与Vertex达成合作|21健讯Daily
药明生物与Vertex就创新三特异性T细胞衔接子达成授权和研究服务协议
人民财讯 · 02-03
药明生物与Vertex就创新三特异性T细胞衔接子达成授权和研究服务协议
福泰制药：加拿大皇家银行上调评级至跑赢大盘，目标价升至546美元
美股速递 · 01-22
福泰制药：加拿大皇家银行上调评级至跑赢大盘，目标价升至546美元
福泰制药盘中异动 下午盘快速跳水3.02%
市场透视 · 01-09
福泰制药盘中异动 下午盘快速跳水3.02%
AI狂欢过后如何备战2026？这四只“攻守兼备”的防御性股票值得关注
智通财经 · 2025-12-19
AI狂欢过后如何备战2026？这四只“攻守兼备”的防御性股票值得关注
福泰制药：与老年患者研究一致，接受Casgevy治疗的儿童在胎儿血红蛋白方面具有持久增加及稳定的等位基因编辑
美股速递 · 2025-12-06
福泰制药：与老年患者研究一致，接受Casgevy治疗的儿童在胎儿血红蛋白方面具有持久增加及稳定的等位基因编辑
福泰制药在美国血液学会年会上发布关于Casgevy®的新数据，首次披露5至11岁儿童的相关数据，并公告全球监管申请计划
美股速递 · 2025-12-06
福泰制药在美国血液学会年会上发布关于Casgevy®的新数据，首次披露5至11岁儿童的相关数据，并公告全球监管申请计划
福泰制药：展示关于Casgevy的新数据，包括5至11岁儿童的首次数据
美股速递 · 2025-12-06
福泰制药：展示关于Casgevy的新数据，包括5至11岁儿童的首次数据
福泰制药：预计将在2026年上半年启动针对5-11岁儿童的Casgevy全球监管申请
美股速递 · 2025-12-06
福泰制药：预计将在2026年上半年启动针对5-11岁儿童的Casgevy全球监管申请
福泰制药：Casgevy在儿童中的安全性与骨髓消融治疗、自体移植在镰状细胞病和再生障碍性贫血中的一致性
美股速递 · 2025-12-06
福泰制药：Casgevy在儿童中的安全性与骨髓消融治疗、自体移植在镰状细胞病和再生障碍性贫血中的一致性
福泰制药股票在盘前交易中上涨1.1%，因摩根士丹利将评级从“平衡配置”上调至“超配”
美股速递 · 2025-12-03
福泰制药股票在盘前交易中上涨1.1%，因摩根士丹利将评级从“平衡配置”上调至“超配”
福泰制药第三季度调整后每股收益为4.8美元，超过IBES预期的4.56美元
投资观察 · 2025-11-20
福泰制药第三季度调整后每股收益为4.8美元，超过IBES预期的4.56美元
一周美股牛榜 | 美国雅保周涨18%，获大行高看至107美元；礼来升近11%，本周创新高；思科周内涨10%
老虎资讯综合 · 2025-11-17
一周美股牛榜 | 美国雅保周涨18%，获大行高看至107美元；礼来升近11%，本周创新高；思科周内涨10%
加载更多
公司概况
公司名称：
福泰制药
所属市场：
NASDAQ
上市日期：
--
主营业务：
Vertex Pharmaceuticals Incorporated于1989年在马萨诸塞州注册成立，是一家全球性的生物技术公司，致力于科学创新，旨在为患有严重疾病的个人，特别是在专业市场创造变革性药物。该公司已开发出针对囊性纤维化、镰状细胞病、输血依赖性β地中海贫血和急性疼痛等病症的获批疗法。该公司不断创新，推进跨越各种严重疾病的下一代临床和研究项目，包括IgA肾病和1型糖尿病等。
发行价格：
--
{"stockData":{"symbol":"VRTX","market":"US","secType":"STK","nameCN":"福泰制药","latestPrice":464.78,"timestamp":1772730745141,"preClose":477.89,"halted":0,"volume":326207,"delay":0,"changeRate":-0.027433091297160463,"floatShares":253718831,"shares":253718831,"eps":15.32,"marketStatus":"交易中","change":-13.11,"latestTime":"03-05 12:12:30 EST","open":476.64,"high":480,"low":462.84,"amount":153053910.4682,"amplitude":0.035908,"askPrice":465.05,"askSize":1,"bidPrice":464.47,"bidSize":15,"shortable":3,"etf":0,"ttmEps":15.32,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772744400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":477.89,"preHourTrading":{"tag":"盘前","latestPrice":478.0207,"preClose":477.89,"latestTime":"09:29 EST","volume":922,"amount":439421.06944,"timestamp":1772720999999,"change":0.1307,"changeRate":0.000273,"amplitude":0.019334},"postHourTrading":{"tag":"盘后","latestPrice":477.8,"preClose":477.89,"latestTime":"19:40 EST","volume":91504,"amount":43728636.8443,"timestamp":1772671228094,"change":-0.09,"changeRate":-0.000188,"amplitude":0.000188},"volumeRatio":0.63194,"impliedVol":0.4689,"impliedVolPercentile":0.9761},"requestUrl":"/m/hq/s/VRTX","defaultTab":"news","newsList":[{"id":"2614022289","title":"Vertex, Inc.盘中异动 早盘股价大涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614022289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614022289?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:32","pubTimestamp":1772116342,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日22时32分，Vertex, Inc.股票出现波动，股价快速拉升5.60%。截至发稿，该股报14.14美元/股，成交量8.4226万股，换手率0.05%，振幅1.12%。Vertex, Inc.股票所在的软件服务行业中，整体涨幅为0.95%。Vertex, Inc.公司简介：Vertex Inc是一家提供税务技术和服务的公司。Vertex为特定行业提供基于云和内部部署的解决方案，涵盖收入、销售、消费者使用、增值和工资等各个税种。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223222a722dcc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223222a722dcc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJJMRZ35.SGD","LU0289739699.SGD","IE0009355771.USD","LU1559883803.SGD","IE0002141913.USD","LU0823416689.USD","IE00B2B36J28.USD","LU2362541273.HKD","SG9999001176.SGD","BK4023","IE0002270589.USD","LU2362540622.SGD","SG9999001176.USD","IE00B894F039.SGD","VRTX","SG9999013999.USD","BK4585","SGXZ57979304.SGD","LU1815336091.USD","LU2237438978.USD","LU1093756325.SGD","LU0079474960.USD","LU0566484027.USD","IE00B19Z9Z06.USD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0432979614.USD","LU2462157665.USD","LU0058720904.USD","LU0417517546.SGD","LU1430594728.SGD","LU0757428866.USD","LU0320765992.SGD","LU2236285917.USD","BK4532","LU1069344957.HKD","LU1093756168.USD","IE00BFTCPJ56.SGD","LU0061475181.USD","VERX","LU2456880835.USD","IE00B19Z3B42.SGD","LU1035775433.USD","BK4588","IE00BZ9MQY76.HKD","LU0234570918.USD","LU0889565916.HKD","BK4139","LU0256863811.USD","LU1778281490.HKD"],"gpt_icon":0},{"id":"2612723489","title":"Vertex, Inc.盘中异动 早盘急速上涨6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612723489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612723489?lang=zh_cn&edition=full","pubTime":"2026-02-19 22:31","pubTimestamp":1771511467,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日22时31分，Vertex, Inc.股票出现异动，股价急速拉升6.53%。Vertex, Inc.股票所在的软件服务行业中，整体跌幅为0.09%。Vertex, Inc.公司简介：Vertex Inc是一家提供税务技术和服务的公司。Vertex为特定行业提供基于云和内部部署的解决方案，涵盖收入、销售、消费者使用、增值和工资等各个税种。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219223107a70a7cc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219223107a70a7cc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234570918.USD","BK4585","IE00B19Z3581.USD","IE00BZ9MQY76.HKD","LU0109394709.USD","LU0823416689.USD","LU1430594728.SGD","VRTX","LU0889565916.HKD","LU1069344957.HKD","LU2456880835.USD","SG9999013999.USD","LU0061475181.USD","LU1035775433.USD","LU0289739699.SGD","LU0079474960.USD","LU0320765992.SGD","LU1093756168.USD","LU1585245621.USD","IE00B19Z9P08.USD","SG9999001176.USD","BK4567","IE00B19Z9Z06.USD","LU0417517546.SGD","LU1674673691.USD","SGXZ57979304.SGD","LU1674673428.USD","LU0256863811.USD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU2462157665.USD","LU2362541513.USD","IE00B894F039.SGD","IE00B2B36J28.USD","LU2362541273.HKD","BK4533","LU0432979614.USD","VERX","LU2236285917.USD","BK4588","LU1778281490.HKD","LU1559883803.SGD","LU2237438978.USD","BK4139","IE0009355771.USD","IE00B19Z3B42.SGD","IE0002270589.USD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU0757428866.USD"],"gpt_icon":0},{"id":"1134175666","title":"福泰制药：积极筹备Povetacicept治疗IgAN的近期商业化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1134175666","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134175666?lang=zh_cn&edition=full","pubTime":"2026-02-13 05:02","pubTimestamp":1770930138,"startTime":"0","endTime":"0","summary":"福泰制药正加速推进Povetacicept针对IgA肾病（IgAN）的近期商业化布局。这款备受关注的治疗药物目前已完成关键临床阶段，公司已启动市场准入策略制定、产能规划及医保谈判等系统性准备工作。随着全球IgAN患者人群的医疗需求持续扩大，该药物的商业化落地有望为福泰制药打开新的增长空间。行业分析师指出，若Povetacicept如期获批，或将重塑自身免疫性疾病治疗领域的市场格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0061475181.USD","LU0289739699.SGD","LU1778281490.HKD","SG9999001176.SGD","LU2362540622.SGD","BK4588","LU1585245621.USD","IE00BFTCPJ56.SGD","LU2417539215.USD","LU1035775433.USD","LU2362541513.USD","LU0079474960.USD","IE00B894F039.SGD","BK4567","LU0432979614.USD","LU0417517546.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU0256863811.USD","IE00BZ9MQY76.HKD","LU2362541273.HKD","LU0234570918.USD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU0823416689.USD","SG9999013999.USD","BK4139","LU2456880835.USD","LU1430594728.SGD","LU2324357040.USD","VRTX","BK4585","LU2236285917.USD","IE00BJT1NW94.SGD","LU0109394709.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2462157665.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU0058720904.USD","LU1069344957.HKD","BK4532","IE0002141913.USD","LU1093756325.SGD","SG9999001176.USD","LU2237438978.USD","LU1674673691.USD","BK4533","IE00B2B36J28.USD","LU1093756168.USD","LU1674673428.USD"],"gpt_icon":0},{"id":"2611213451","title":"Vertex, Inc.盘中异动 临近午盘股价大跌5.18%报12.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611213451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611213451?lang=zh_cn&edition=full","pubTime":"2026-02-13 00:31","pubTimestamp":1770913890,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日00时31分，Vertex, Inc.股票出现波动，股价快速跳水5.18%。截至发稿，该股报12.17美元/股，成交量95.6528万股，换手率0.60%，振幅5.57%。Vertex, Inc.股票所在的软件服务行业中，整体跌幅为2.36%。其相关个股中，Chowchow Cloud International Holdings Limited、Fastly, Inc.、Signing Day Sports, Inc.涨幅较大，Signing Day Sports, Inc.、Chowchow Cloud International Holdings Limited、Jet.AI较为活跃，换手率分别为2256.74%、719.94%、262.54%，振幅较大的相关个股有Chowchow Cloud International Holdings Limited、索威尔、Signing Day Sports, Inc.，振幅分别为125.53%、40.56%、38.08%。Vertex, Inc.公司简介：Vertex Inc是一家提供税务技术和服务的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213003130a49d33da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213003130a49d33da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0289739699.SGD","LU0432979614.USD","LU0417517546.SGD","IE00B19Z3581.USD","LU1093756168.USD","LU2462157665.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","LU0320765992.SGD","LU1035775433.USD","SGXZ57979304.SGD","LU0061475181.USD","BK4588","BK4533","LU2324357040.USD","LU0234570918.USD","IE00BFTCPJ56.SGD","LU0566484027.USD","IE00BJT1NW94.SGD","VERX","LU0256863811.USD","LU0757428866.USD","LU0109394709.USD","LU1430594728.SGD","LU2456880835.USD","LU0079474960.USD","IE00B19Z9P08.USD","LU2237438978.USD","LU0823416689.USD","VRTX","LU2362541273.HKD","LU1815336091.USD","LU0889565916.HKD","LU1674673428.USD","SG9999001176.SGD","LU2362541513.USD","LU1559883803.SGD","BK4567","SG9999013999.USD","LU1778281490.HKD","SG9999001176.USD","IE0009355771.USD","LU1674673691.USD","LU2362540622.SGD","LU1069344957.HKD","IE0002270589.USD","LU2236285917.USD","IE00B2B36J28.USD","IE00B894F039.SGD","IE0002141913.USD"],"gpt_icon":0},{"id":"2609907547","title":"福泰制药盘中异动 股价大涨3.02%报472.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609907547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609907547?lang=zh_cn&edition=full","pubTime":"2026-02-07 00:32","pubTimestamp":1770395576,"startTime":"0","endTime":"0","summary":"北京时间2026年02月07日00时32分，福泰制药股票出现异动，股价大幅上涨3.02%。截至发稿，该股报472.66美元/股，成交量42.8508万股，换手率0.17%，振幅2.83%。最近的财报数据显示，该股实现营业收入31.15亿美元，净利润10.83亿美元，每股收益4.24美元，毛利27.01亿美元，市盈率33.22倍。福泰制药股票所在的生物技术行业中，整体涨幅为1.44%。其中福泰疗法仍然是全球治疗囊性纤维化的标准。此外，福泰正在评估APOL1介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020700325697a53e48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020700325697a53e48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0061475181.USD","LU0289739699.SGD","LU1778281490.HKD","SG9999001176.SGD","LU2362540622.SGD","BK4588","LU1585245621.USD","LU2417539215.USD","LU1035775433.USD","LU2362541513.USD","IE00B894F039.SGD","BK4567","LU0432979614.USD","LU0417517546.SGD","IE00B19Z3581.USD","LU0256863811.USD","LU2362541273.HKD","SGXZ57979304.SGD","LU0234570918.USD","LU0823416689.USD","SG9999013999.USD","BK4139","LU2456880835.USD","LU1430594728.SGD","LU2324357040.USD","VRTX","BK4585","LU2236285917.USD","IE00BJT1NW94.SGD","LU0109394709.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2462157665.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU0058720904.USD","LU1069344957.HKD","BK4532","IE0002141913.USD","LU1093756325.SGD","SG9999001176.USD","LU2237438978.USD","LU1674673691.USD","BK4533","IE00B2B36J28.USD","LU1093756168.USD","LU1674673428.USD"],"gpt_icon":0},{"id":"1112986288","title":"财报前瞻｜福泰制药本季度营收预计增14.16%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1112986288","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112986288?lang=zh_cn&edition=full","pubTime":"2026-02-05 10:04","pubTimestamp":1770257088,"startTime":"0","endTime":"0","summary":"福泰制药将于2026年02月12日发布最新季度财报，市场关注核心CF业务韧性与新产品放量带来的增长确定性及盈利质量变化。市场一致预期本季度福泰制药营收为31.74亿美元，同比增长14.16%；毛利率、净利率及调整后每股收益的具体本季度预测，市场未给出足够一致的量化数据；本季度预测的每股收益为5.07美元，同比增长25.87%，息税前利润为14.46亿美元，同比增长23.59%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜福泰制药本季度营收预计增14.16%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX"],"gpt_icon":0},{"id":"2608350097","title":"药明生物与Vertex达成TCE合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2608350097","media":"医药健闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608350097?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:09","pubTimestamp":1770188940,"startTime":"0","endTime":"0","summary":" CRDMO药明生物宣布，已与Vertex Pharmaceuticals Incorporated签署一项针对创新三特异性T细胞衔接子的授权和研究服务协议，该TCE用于治疗B细胞介导的自身免疫性疾病。根据协议，Vertex拥有该处于临床前阶段的创新三特异性TCE的全球独家开发和商业化权利。药明生物将获得首付款，并有资格获得开发、监管和销售里程碑付款以及特许权使用费，同时还将为Vertex提供新一代TCE的合同研发服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204151000a6d1a8e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204151000a6d1a8e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","IE0002270589.USD","LU0289739699.SGD","SG9999001176.SGD","LU0061475181.USD","LU2462157665.USD","LU1069344957.HKD","BK4532","LU2417539215.USD","LU2362541273.HKD","LU1674673691.USD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0889565916.HKD","LU1093756325.SGD","LU2236285917.USD","LU0256863811.USD","LU0417517546.SGD","BK4567","BK4585","LU2362541513.USD","LU0823416689.USD","IE00BFTCPJ56.SGD","LU2362540622.SGD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","VRTX","LU1430594728.SGD","BK4139","IE0002141913.USD","BK4533","LU0320765992.SGD","LU2324357040.USD","BK4023","LU1778281490.HKD","IE00B894F039.SGD","SG9999001176.USD","IE00B19Z9Z06.USD","LU0234570918.USD","LU1585245621.USD","VERX","LU0432979614.USD","LU0566484027.USD","IE00B19Z9P08.USD","BK4588","IE00B19Z3581.USD","IE00BZ9MQY76.HKD","LU0079474960.USD","LU0757428866.USD","LU1093756168.USD"],"gpt_icon":0},{"id":"2608438490","title":"英硅智能获里程碑付款；药明生物与Vertex达成合作|21健讯Daily","url":"https://stock-news.laohu8.com/highlight/detail?id=2608438490","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608438490?lang=zh_cn&edition=full","pubTime":"2026-02-04 08:09","pubTimestamp":1770163752,"startTime":"0","endTime":"0","summary":"这里是《21健讯Daily》，欢迎与21世纪经济报道新健康团队共同关注医药健康行业最新事件！政策动向上海：大力培育发展脑机接口等未来产业上海市第十六届人大四次会议2月3日上午在世博中心开幕。上海市市长龚正作《政府工作报告》。报告表示，今年要推进临港科创城建设，加快打造一批高水平科创社区，持续提升东方芯港、大飞机园等特色产业园区能级，大力培育发展脑机接口、第四代半导体等未来产业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602043640744690.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602043640744690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0516423174.USD","BK1589","LU0417516738.SGD","LU0456827905.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0320765992.SGD","LU2237438978.USD","LU0326950275.SGD","LU0417517546.SGD","LU0856984785.SGD","BK4532","LU1585245621.USD","IE00BZ9MQY76.HKD","LU0039217434.USD","IE00BFTCPJ56.SGD","LU0516423091.SGD","BK4023","IE0009355771.USD","LU1093756168.USD","IE00B19Z3581.USD","LU0043850808.USD","LU1674673428.USD","BK1521","LU0516422366.SGD","BK4533","LU2456880835.USD","LU0456846285.SGD","LU0708995583.HKD","02269","SG9999002562.SGD","LU0109394709.USD","VRTX","LU2417539215.USD","LU2362541273.HKD","SG9999013999.USD","LU1242518931.SGD","IE00B0JY6N72.USD","BK4567","IE0002270589.USD","LU0359202008.SGD","VERX","LU1430594728.SGD","BK1610","IE00BJT1NW94.SGD","LU3063872942.SGD","IE00B894F039.SGD","LU0052750758.USD","LU1688375341.USD","LU0348735423.USD"],"gpt_icon":0},{"id":"2608581451","title":"药明生物与Vertex就创新三特异性T细胞衔接子达成授权和研究服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2608581451","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608581451?lang=zh_cn&edition=full","pubTime":"2026-02-03 08:47","pubTimestamp":1770079632,"startTime":"0","endTime":"0","summary":"人民财讯2月3日电，2月3日，药明生物宣布与VertexPharmaceuticals（纳斯达克代码：VRTX）已针对一款创新三特异性T细胞衔接子（TCE）签署授权和研究服务协议。Vertex计划用于治疗B细胞介导的自身免疫性疾病。根据协议条款，Vertex将获得该处于临床前阶段、计划用于治疗B细胞介导的自免疾病的三特异性TCE的全球独家开发及商业化权益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602033639376886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0456846285.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU1035775433.USD","IE00B894F039.SGD","LU0823426480.USD","LU1242518857.USD","LU2462157665.USD","LU1093756325.SGD","SG9999013999.USD","LU0516423091.SGD","BK4585","LU0348735423.USD","LU0516422440.USD","LU0058720904.USD","LU1674673691.USD","02269","LU0327786744.USD","BK4588","LU0348825331.USD","LU0061475181.USD","LU0320765992.SGD","BK1521","LU1674673428.USD","LU2324357040.USD","BK1589","LU2362541273.HKD","LU2362541513.USD","LU1815336091.USD","IE00B19Z3B42.SGD","LU0307460666.USD","LU0417516902.SGD","BK1610","IE00B0JY6N72.USD","LU0979878070.USD","LU0566484027.USD","LU1720050803.USD","LU0823426308.USD","LU0181495838.USD","LU0234570918.USD","LU0819121731.USD","LU0856984785.SGD","VRTX","SG9999002562.SGD","LU0359202008.SGD","LU0456827905.SGD","LU1880383366.USD","IE0002141913.USD","VERX","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"1187198499","title":"福泰制药：加拿大皇家银行上调评级至跑赢大盘，目标价升至546美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187198499","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187198499?lang=zh_cn&edition=full","pubTime":"2026-01-22 18:36","pubTimestamp":1769078198,"startTime":"0","endTime":"0","summary":"加拿大皇家银行(RBC)发布最新研报，将福泰制药(Vertex Pharmaceuticals)的股票评级从\"板块同步\"调升至\"跑赢大盘\"。\n与此同时，该行将福泰制药的目标股价从455美元大幅上调至546美元，显示出对该公司未来业绩的强劲信心。\n此次评级调整反映了分析师对福泰制药在创新药物研发和市场拓展方面的积极预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","IE00BZ9MQY76.HKD","BK4533","LU2237438978.USD","LU2236285917.USD","LU2362541513.USD","LU2456880835.USD","LU0061475181.USD","BK4585","LU0289739699.SGD","LU0109394709.USD","LU0889565916.HKD","SGXZ57979304.SGD","LU0417517546.SGD","LU1093756168.USD","LU1093756325.SGD","LU2362541273.HKD","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU1430594728.SGD","LU1674673428.USD","IE00B894F039.SGD","IE00B2B36J28.USD","BK4532","IE00B19Z9P08.USD","IE00BFTCPJ56.SGD","LU2362540622.SGD","SG9999001176.USD","SG9999013999.USD","VRTX","IE00B19Z3581.USD","LU0320765992.SGD","IE0002141913.USD","LU0079474960.USD","LU0256863811.USD","LU2417539215.USD","BK4567","LU0823416689.USD","LU0234570918.USD","BK4588","IE0009355771.USD","SG9999001176.SGD","LU1035775433.USD","IE0002270589.USD","LU1674673691.USD","LU1069344957.HKD","LU2324357040.USD","LU1778281490.HKD","LU1585245621.USD","LU0058720904.USD","IE00B4R5TH58.HKD","BK4139","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2602316000","title":"福泰制药盘中异动 下午盘快速跳水3.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602316000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602316000?lang=zh_cn&edition=full","pubTime":"2026-01-09 03:11","pubTimestamp":1767899486,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日03时11分，福泰制药股票出现异动，股价大幅下挫3.02%。截至发稿，该股报469.52美元/股，成交量82.1422万股，换手率0.32%，振幅3.29%。福泰制药股票所在的生物技术行业中，整体跌幅为1.88%。福泰制药公司简介：福泰制药是一家全球性的生物技术公司，致力于发现和开发用于治疗严重疾病的小分子药物。其中福泰疗法仍然是全球治疗囊性纤维化的标准。此外，福泰正在评估APOL1介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109031126a4ad14f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109031126a4ad14f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0289739699.SGD","LU2236285917.USD","IE00B19Z3581.USD","BK4533","LU0234570918.USD","LU0417517546.SGD","SGXZ57979304.SGD","LU1035775433.USD","BK4139","VRTX","LU1674673428.USD","IE00B19Z9Z06.USD","IE0002141913.USD","LU1674673691.USD","LU1430594728.SGD","BK4567","IE0009355771.USD","LU0889565916.HKD","IE00B894F039.SGD","LU2362541513.USD","BK4588","IE0002270589.USD","LU1069344957.HKD","LU2237438978.USD","IE00B19Z9P08.USD","LU0320765992.SGD","LU2362540622.SGD","LU2462157665.USD","IE00BJT1NW94.SGD","LU1778281490.HKD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU2417539215.USD","IE00B4R5TH58.HKD","LU0061475181.USD","BK4585","BK4532","LU2456880835.USD","LU2324357040.USD","LU1093756325.SGD","IE00BZ9MQY76.HKD","LU1585245621.USD","LU1093756168.USD","SG9999013999.USD","IE00B19Z3B42.SGD","LU0079474960.USD","LU2362541273.HKD","LU0823416689.USD","LU0432979614.USD"],"gpt_icon":0},{"id":"2592155281","title":"AI狂欢过后如何备战2026？这四只“攻守兼备”的防御性股票值得关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2592155281","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592155281?lang=zh_cn&edition=full","pubTime":"2025-12-19 15:05","pubTimestamp":1766127943,"startTime":"0","endTime":"0","summary":"如果2026年科技板块降温且经济增长保持温和而非强劲，这些公司可能成为当前值得买入的最佳防御性股票。收益率、通胀保护和盈利增长的结合，使该公司成为2026年防御性配置的基础性持仓。Iberdrola的基本面优势已转化为其在2025年表现动量方面的板块领先地位，这一势头在2026年有望延续。这些股票共同表明，防御性投资不一定枯燥或停滞不前，2026年最佳的防御性股票可能是那些既能保护资本，又能选择性实现资本增长的标的。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"85e8aafb51ba0ad706197d405ff70b96","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383591.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AI狂欢过后如何备战2026？这四只“攻守兼备”的防御性股票值得关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VRTX","BRKR","INCY","IBDRY"],"gpt_icon":1},{"id":"1164017239","title":"福泰制药：与老年患者研究一致，接受Casgevy治疗的儿童在胎儿血红蛋白方面具有持久增加及稳定的等位基因编辑","url":"https://stock-news.laohu8.com/highlight/detail?id=1164017239","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164017239?lang=zh_cn&edition=full","pubTime":"2025-12-06 20:02","pubTimestamp":1765022532,"startTime":"0","endTime":"0","summary":"福泰制药：与老年患者研究一致，接受Casgevy治疗的儿童在胎儿血红蛋白方面具有持久增加及稳定的等位基因编辑","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","LU1069344957.HKD","LU2237438978.USD","LU0061475181.USD","IE00BJT1NW94.SGD","LU0109394709.USD","LU1585245621.USD","LU2417539215.USD","LU2456880835.USD","SG9999013999.USD","IE0002270589.USD","SGXZ57979304.SGD","IE0009355771.USD","LU1430594728.SGD","SG9999001176.SGD","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","LU2362540622.SGD","BK4532","LU1778281490.HKD","LU0079474960.USD","IE00B19Z9P08.USD","LU2324357040.USD","LU2462157665.USD","LU2362541273.HKD","IE0002141913.USD","LU0432979614.USD","IE00B19Z9Z06.USD","LU0320765992.SGD","IE00B2B36J28.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2236285917.USD","VRTX","LU0234570918.USD","IE00B894F039.SGD","LU0417517546.SGD","LU1035775433.USD","LU2362541513.USD","BK4585","LU0256863811.USD","LU0889565916.HKD","IE00B19Z3581.USD","LU0823416689.USD","LU0058720904.USD","BK4533","BK4139","LU1093756325.SGD","BK4588","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU1093756168.USD","LU1674673428.USD","LU1674673691.USD"],"gpt_icon":0},{"id":"1127342118","title":"福泰制药在美国血液学会年会上发布关于Casgevy®的新数据，首次披露5至11岁儿童的相关数据，并公告全球监管申请计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1127342118","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127342118?lang=zh_cn&edition=full","pubTime":"2025-12-06 20:01","pubTimestamp":1765022501,"startTime":"0","endTime":"0","summary":"福泰制药在美国血液学会年会上发布关于Casgevy®的新数据，首次披露5至11岁儿童的相关数据，并公告全球监管申请计划","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU1778281490.HKD","SGXZ57979304.SGD","BK4588","LU1093756325.SGD","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","LU0061475181.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","LU0256863811.USD","LU0234570918.USD","LU2236285917.USD","SG9999001176.USD","BK4533","LU0320765992.SGD","LU1093756168.USD","BK4585","LU0058720904.USD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU2362541273.HKD","LU2324357040.USD","LU0889565916.HKD","BK4567","IE0002141913.USD","IE00B894F039.SGD","LU1430594728.SGD","SG9999001176.SGD","LU2362540622.SGD","LU0823416689.USD","LU0417517546.SGD","IE00BZ9MQY76.HKD","IE0002270589.USD","IE00B19Z3581.USD","LU1035775433.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2237438978.USD","LU2417539215.USD","SG9999013999.USD","BK4532","LU2456880835.USD","IE0009355771.USD","LU0109394709.USD","LU2462157665.USD","VRTX","LU0432979614.USD","LU1674673428.USD","LU2362541513.USD","LU0079474960.USD","LU1585245621.USD","BK4139","LU1069344957.HKD"],"gpt_icon":0},{"id":"1186393095","title":"福泰制药：展示关于Casgevy的新数据，包括5至11岁儿童的首次数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1186393095","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186393095?lang=zh_cn&edition=full","pubTime":"2025-12-06 20:01","pubTimestamp":1765022499,"startTime":"0","endTime":"0","summary":"福泰制药：展示关于Casgevy的新数据，包括5至11岁儿童的首次数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0432979614.USD","IE00B19Z3581.USD","LU1093756168.USD","SG9999013999.USD","BK4532","LU0823416689.USD","VRTX","LU0061475181.USD","BK4588","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4533","LU1674673428.USD","IE0009355771.USD","LU0109394709.USD","LU0256863811.USD","SGXZ57979304.SGD","IE0002270589.USD","IE00B2B36J28.USD","LU1778281490.HKD","LU2456880835.USD","IE00BJJMRZ35.SGD","IE00B894F039.SGD","IE00B19Z3B42.SGD","LU1430594728.SGD","LU2236285917.USD","LU0417517546.SGD","LU2417539215.USD","SG9999001176.SGD","BK4585","LU2362541273.HKD","SG9999001176.USD","LU1674673691.USD","LU1585245621.USD","LU2362540622.SGD","IE00B19Z9Z06.USD","BK4139","LU2462157665.USD","IE0002141913.USD","LU0289739699.SGD","LU0889565916.HKD","IE00B19Z9P08.USD","LU2362541513.USD","LU0320765992.SGD","LU1035775433.USD","LU1093756325.SGD","LU0079474960.USD","IE00B4R5TH58.HKD","LU2237438978.USD","LU1069344957.HKD","IE00BZ9MQY76.HKD","BK4567","LU0234570918.USD"],"gpt_icon":0},{"id":"1199949266","title":"福泰制药：预计将在2026年上半年启动针对5-11岁儿童的Casgevy全球监管申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1199949266","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199949266?lang=zh_cn&edition=full","pubTime":"2025-12-06 20:00","pubTimestamp":1765022457,"startTime":"0","endTime":"0","summary":"福泰制药：预计将在2026年上半年启动针对5-11岁儿童的Casgevy全球监管申请","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","IE00BZ9MQY76.HKD","BK4533","LU2237438978.USD","LU2236285917.USD","LU2362541513.USD","LU2456880835.USD","LU0061475181.USD","BK4585","LU0289739699.SGD","LU0109394709.USD","LU0889565916.HKD","SGXZ57979304.SGD","LU0417517546.SGD","LU1093756168.USD","LU1093756325.SGD","LU2362541273.HKD","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU1430594728.SGD","LU1674673428.USD","IE00B894F039.SGD","IE00B2B36J28.USD","BK4532","IE00B19Z9P08.USD","IE00BFTCPJ56.SGD","LU2362540622.SGD","SG9999001176.USD","SG9999013999.USD","VRTX","IE00B19Z3581.USD","LU0320765992.SGD","IE0002141913.USD","LU0079474960.USD","LU0256863811.USD","LU2417539215.USD","BK4567","LU0823416689.USD","LU0234570918.USD","BK4588","IE0009355771.USD","SG9999001176.SGD","LU1035775433.USD","IE0002270589.USD","LU1674673691.USD","LU1069344957.HKD","LU2324357040.USD","LU1778281490.HKD","LU1585245621.USD","LU0058720904.USD","IE00B4R5TH58.HKD","BK4139","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"1155714554","title":"福泰制药：Casgevy在儿童中的安全性与骨髓消融治疗、自体移植在镰状细胞病和再生障碍性贫血中的一致性","url":"https://stock-news.laohu8.com/highlight/detail?id=1155714554","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155714554?lang=zh_cn&edition=full","pubTime":"2025-12-06 20:00","pubTimestamp":1765022450,"startTime":"0","endTime":"0","summary":"福泰制药：Casgevy在儿童中的安全性与骨髓消融治疗、自体移植在镰状细胞病和再生障碍性贫血中的一致性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","BK4139","IE00B4R5TH58.HKD","LU2417539215.USD","LU2236285917.USD","LU0417517546.SGD","LU2362540622.SGD","LU1778281490.HKD","LU0061475181.USD","LU0109394709.USD","LU0234570918.USD","LU0823416689.USD","LU1585245621.USD","IE00BZ9MQY76.HKD","IE0002141913.USD","IE0002270589.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU1674673691.USD","LU1035775433.USD","LU0320765992.SGD","LU2462157665.USD","BK4567","BK4585","LU0432979614.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU2324357040.USD","LU0256863811.USD","SG9999001176.SGD","BK4533","LU1674673428.USD","BK4588","LU0889565916.HKD","IE00B894F039.SGD","LU2362541513.USD","SG9999013999.USD","SG9999001176.USD","IE00B19Z3B42.SGD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU1093756325.SGD","LU2456880835.USD","IE00BJT1NW94.SGD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","LU1069344957.HKD","LU2237438978.USD","LU1430594728.SGD","IE00B19Z9P08.USD","LU2362541273.HKD","VRTX","LU1093756168.USD","LU0079474960.USD","BK4532"],"gpt_icon":0},{"id":"1144865547","title":"福泰制药股票在盘前交易中上涨1.1%，因摩根士丹利将评级从“平衡配置”上调至“超配”","url":"https://stock-news.laohu8.com/highlight/detail?id=1144865547","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144865547?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:27","pubTimestamp":1764764835,"startTime":"0","endTime":"0","summary":"福泰制药股票在盘前交易中上涨1.1%，因摩根士丹利将评级从“平衡配置”上调至“超配”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0061475181.USD","LU0289739699.SGD","LU1778281490.HKD","SG9999001176.SGD","LU2362540622.SGD","BK4588","LU1585245621.USD","IE00BFTCPJ56.SGD","LU2417539215.USD","LU1035775433.USD","LU2362541513.USD","LU0079474960.USD","IE00B894F039.SGD","BK4567","LU0432979614.USD","LU0417517546.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU0256863811.USD","IE00BZ9MQY76.HKD","LU2362541273.HKD","LU0234570918.USD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU0823416689.USD","SG9999013999.USD","BK4139","LU2456880835.USD","LU1430594728.SGD","LU2324357040.USD","VRTX","BK4585","LU2236285917.USD","IE00BJT1NW94.SGD","LU0109394709.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2462157665.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU0058720904.USD","LU1069344957.HKD","BK4532","IE0002141913.USD","LU1093756325.SGD","SG9999001176.USD","LU2237438978.USD","LU1674673691.USD","BK4533","IE00B2B36J28.USD","LU1093756168.USD","LU1674673428.USD"],"gpt_icon":0},{"id":"1186338357","title":"福泰制药第三季度调整后每股收益为4.8美元，超过IBES预期的4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186338357","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186338357?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:32","pubTimestamp":1763569967,"startTime":"0","endTime":"0","summary":"11月3日 - 福泰制药第三季度调整后净收入为10.829亿美元，低于IBES预期的11.9亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","SG9999001176.SGD","IE0002141913.USD","LU0109394709.USD","LU1069344957.HKD","LU2362540622.SGD","LU2236285917.USD","BK4533","BK4139","VRTX","LU0417517546.SGD","LU2362541273.HKD","SG9999001176.USD","LU2462157665.USD","LU1430594728.SGD","IE0002270589.USD","LU0823416689.USD","BK4585","LU0889565916.HKD","BK4567","LU1674673428.USD","IE00B19Z9P08.USD","IE00BZ9MQY76.HKD","IE0009355771.USD","LU2417539215.USD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1585245621.USD","LU0432979614.USD","SG9999013999.USD","IE00B19Z3581.USD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","BK4532","LU0256863811.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU0061475181.USD","IE00B4R5TH58.HKD","LU0234570918.USD","LU1035775433.USD","LU1093756168.USD","IE00BJT1NW94.SGD","LU1778281490.HKD","LU2237438978.USD","LU0079474960.USD","LU2456880835.USD","LU1093756325.SGD","BK4588","LU2362541513.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU1674673691.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"1144209379","title":"一周美股牛榜 | 美国雅保周涨18%，获大行高看至107美元；礼来升近11%，本周创新高；思科周内涨10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144209379","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144209379?lang=zh_cn&edition=full","pubTime":"2025-11-17 10:48","pubTimestamp":1763347698,"startTime":"0","endTime":"0","summary":"瑞穗证券将其目标价从92美元上调至110美元，瑞银将其目标价从85美元上调至107美元。礼来升10%，股票本周创历史新高礼来公司的股票本周达到历史新高，达到每股1025美元，此前几笔重大交易促使美国食品和药物管理局对其备受期待的减肥药orforglipron进行了快速审查。","market":"us","thumbnail":"https://community-static.tradeup.com/news/b709e81a1b4f7405bf5e343b3c9425a7","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b709e81a1b4f7405bf5e343b3c9425a7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"aad815d0c6beee6ce1e194810f0ba331","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSCO","IFF","LLY","BDX","BIIB","VRTX","DVN","ABBV","ALB","MRK"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.vrtx.com","stockEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0125},{"period":"3month","weight":0.0449},{"period":"6month","weight":0.2064},{"period":"1year","weight":-0.0171},{"period":"ytd","weight":0.0541}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0148},{"period":"3month","weight":0.0011},{"period":"6month","weight":0.0585},{"period":"1year","weight":0.1877},{"period":"ytd","weight":0.0047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vertex Pharmaceuticals Incorporated于1989年在马萨诸塞州注册成立，是一家全球性的生物技术公司，致力于科学创新，旨在为患有严重疾病的个人，特别是在专业市场创造变革性药物。该公司已开发出针对囊性纤维化、镰状细胞病、输血依赖性β地中海贫血和急性疼痛等病症的获批疗法。该公司不断创新，推进跨越各种严重疾病的下一代临床和研究项目，包括IgA肾病和1型糖尿病等。","yearOnYearQuotes":[{"month":1,"riseRate":0.657143,"avgChangeRate":0.034393},{"month":2,"riseRate":0.457143,"avgChangeRate":0.001601},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.020157},{"month":4,"riseRate":0.617647,"avgChangeRate":0.018103},{"month":5,"riseRate":0.558824,"avgChangeRate":0.077818},{"month":6,"riseRate":0.558824,"avgChangeRate":0.028419},{"month":7,"riseRate":0.470588,"avgChangeRate":-0.004622},{"month":8,"riseRate":0.628571,"avgChangeRate":0.046325},{"month":9,"riseRate":0.485714,"avgChangeRate":0.030192},{"month":10,"riseRate":0.542857,"avgChangeRate":0.000856},{"month":11,"riseRate":0.485714,"avgChangeRate":-0.02026},{"month":12,"riseRate":0.657143,"avgChangeRate":0.071588}],"exchange":"NASDAQ","name":"福泰制药","nameEN":"Vertex Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福泰制药,VRTX,福泰制药股票,福泰制药股票老虎,福泰制药股票老虎国际,福泰制药行情,福泰制药股票行情,福泰制药股价,福泰制药股市,福泰制药股票价格,福泰制药股票交易,福泰制药股票购买,福泰制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}